Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
SiriusPoint
SPNT
$2.68B
| $551K | ﹤0.01% |
73,367
+9,217
| +14% | +$69.6K |
|
3227
Banc of California
BANC
$2.97B
| $550K | ﹤0.01% |
50,866
+281
| +0.6% | +$2.83K |
|
3228
PUT
Cirrus Logic
CRUS
$6.26B
| $550K | ﹤0.01% |
8,900
-2,100
| -19% | -$144K |
|
|
PPLI
3229
CALL
People Inc
PPLI
$3.1B
| $550K | ﹤0.01% |
9,512
-53,716
| -85% | -$2.39M |
|
3230
CALL
Moody's
MCO
$82.7B
| $549K | ﹤0.01% |
2,000
-7,200
| -78% | -$1.83M |
|
|
EXAS
3231
CALL
DELISTED
Exact Sciences
EXAS
| $548K | ﹤0.01% |
6,300
-165,000
| -96% | -$13.2M |
|
|
GNMK
3232
DELISTED
GenMark Diagnostics, Inc
GNMK
| $548K | ﹤0.01% |
37,278
-1,741
| -4% | -$17.7K |
|
3233
Omeros
OMER
$959M
| $546K | ﹤0.01% |
37,060
+12,510
| +51% | +$187K |
|
3234
PUT
Lear
LEA
$8.18B
| $545K | ﹤0.01% |
5,000
-15,600
| -76% | -$1.55M |
|
3235
CALL
Thomson Reuters
TRI
$44.1B
| $544K | ﹤0.01% |
7,593
-854
| -10% | -$61.8K |
|
3236
PUT
Interactive Brokers
IBKR
$39.8B
| $543K | ﹤0.01% |
52,000
-79,200
| -60% | -$828K |
|
|
AVTA
3237
DELISTED
Avantax, Inc. Common Stock
AVTA
| $543K | ﹤0.01% |
47,542
+2,736
| +6% | +$34.4K |
|
3238
Donnelley Financial Solutions
DFIN
$1.16B
| $542K | ﹤0.01% |
64,473
+4,150
| +7% | +$29.9K |
|
3239
CALL
Etsy
ETSY
$7.85B
| $542K | ﹤0.01% |
5,100
-32,700
| -87% | -$2.42M |
|
|
CLVR
3240
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $542K | ﹤0.01% |
+1,765
| New | +$544K |
|
3241
CALL
Campbell Soup
CPB
$6.87B
| $541K | ﹤0.01% |
10,900
-32,600
| -75% | -$1.62M |
|
|
BPFH
3242
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $541K | ﹤0.01% |
78,574
+11,412
| +17% | +$79.8K |
|
3243
PUT
JetBlue
JBLU
$2.29B
| $540K | ﹤0.01% |
49,500
-266,500
| -84% | -$2.62M |
|
3244
PUT
Alliance Resource Partners
ARLP
$3.17B
| $539K | ﹤0.01% |
165,300
| – | – |
|
3245
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.42B
| $539K | ﹤0.01% |
12,900
-138,000
| -91% | -$5.06M |
|
|
TARO
3246
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $539K | ﹤0.01% |
+8,100
| New | +$543K |
|
3247
PUT
Capital One
COF
$134B
| $538K | ﹤0.01% |
8,600
-39,300
| -82% | -$2.45M |
|
3248
Matthews International
MATW
$739M
| $538K | ﹤0.01% |
28,152
+2,326
| +9% | +$49.6K |
|
|
SLCT
3249
DELISTED
Select Bancorp, Inc.
SLCT
| $537K | ﹤0.01% |
66,014
+48,938
| +287% | +$369K |
|
|
CYBR
3250
PUT
DELISTED
CyberArk
CYBR
| $536K | ﹤0.01% |
5,400
-14,400
| -73% | -$1.4M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.